MCP
PRCT icon

Mirador Capital Partners’s Procept Biorobotics PRCT Stock Holding History

Mirador Capital Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$441K Buy
+19,535
New +$489K 0.05% 165
2026
Q1 		– Sell
-7,480
Closed -$235K – 213
2025
Q4 		$235K Hold
7,480
– – 0.03% 192
2025
Q3 		$267K Hold
7,480
– – 0.04% 185
2025
Q2 		$431K Buy
+7,480
New +$423K 0.07% 150

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mirador Capital Partners's PRCT Position: Q2 2026 in Review

Mirador Capital Partners opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 19,535 shares worth $441K. The stake represents 0.05% of the portfolio and ranks #165 among its holdings. This is a return to the name: Mirador Capital Partners previously reported a position in PRCT as recently as Q4 2025.

Mirador Capital Partners first reported a position in PRCT in Q2 2025 and has held it in 4 quarters since. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Mirador Capital Partners held 19,535 shares of Procept Biorobotics worth $441K as of Q2 2026.
  • Procept Biorobotics was a new Mirador Capital Partners position in Q2 2026.
  • Procept Biorobotics made up 0.05% of Mirador Capital Partners's portfolio in Q2 2026, its #165 holding.
  • Mirador Capital Partners first reported a position in Procept Biorobotics in Q2 2025 and has held it in 4 quarters since.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.